Cascade Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Sell
7,564
-548
-7% -$128K 0.17% 85
2026
Q1
$1.98M Sell
8,112
-164
-2% -$38.2K 0.2% 83
2025
Q4
$1.71M Buy
8,276
+387
+5% +$76.5K 0.17% 89
2025
Q3
$1.46M Sell
7,889
-659
-8% -$113K 0.17% 92
2025
Q2
$1.31M Buy
8,548
+74
+0.9% +$11.4K 0.16% 96
2025
Q1
$1.41M Sell
8,474
-16
-0.2% -$2.5K 0.18% 90
2024
Q4
$1.23M Sell
8,490
-24
-0.3% -$3.72K 0.16% 89
2024
Q3
$1.39M Buy
8,514
+262
+3% +$41.7K 0.17% 82
2024
Q2
$1.21M Sell
8,252
-900
-10% -$134K 0.16% 86
2024
Q1
$1.35M Buy
+9,152
New +$1.46M 0.19% 76

Other funds holding JNJ

Cascade Financial Partners's JNJ Position: Q2 2026 in Review

Cascade Financial Partners reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q2 2026, selling an estimated $128K and leaving 7,564 shares worth $1.92M. The position accounts for 0.17% of the portfolio, ranked #85.

Cascade Financial Partners first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.98M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cascade Financial Partners held 7,564 shares of Johnson & Johnson worth $1.92M as of Q2 2026.
  • Cascade Financial Partners sold 548 Johnson & Johnson shares in Q2 2026, an estimated $128K.
  • Johnson & Johnson made up 0.17% of Cascade Financial Partners's portfolio in Q2 2026, its #85 holding.
  • Cascade Financial Partners first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • Cascade Financial Partners's Johnson & Johnson position peaked at $1.98M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cascade Financial Partners's 13F filing for Q2 2026, filed 4 Aug 2026.